Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, Maj-Linda B., Brownlow, Milene, Jimenez, Jeffy P., Lee, Daniel C., Pena, Gabriela, Dickey, Chad A., Gordon, Marcia N., Morgan, Dave·2013·Neurodegenerative Diseases
DOI 10.1159/000337230

Cited by (1,606)

Items 801–900 of 1,606

  1. Microglia and Aging: The Role of the TREM2–DAP12 and CX3CL1-CX3CR1 Axes
    Carmen Mecca, Ileana Giambanco, Rosario Donato, Cataldo Arcuri · 2018 · International Journal of Molecular Sciences
  2. Noradrenergic Depletion Potentiates β-Amyloid-Induced Cortical Inflammation: Implications for Alzheimer's Disease
    Michael Thomas Heneka, Elena Galea, Vitaliy Gavriluyk, Lucia Dumitrescu‐Ozimek, JoAnna Daeschner, M. Kerry O’Banion, Guy L. Weinberg, Thomas Klockgether, Douglas L. Feinstein · 2002 · Journal of Neuroscience
  3. Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice
    Janelsins, Michelle C, Mastrangelo, Michael A, Oddo, Salvatore, LaFerla, Frank M, Federoff, Howard J, Bowers, William J · 2005 · Journal of Neuroinflammation
  4. RNA-Binding Protein Musashi2: Developmentally Regulated Expression in Neural Precursor Cells and Subpopulations of Neurons in Mammalian CNS
    Shin‐ichi Sakakibara, Yuki Nakamura, Hitoshi Satoh, Hideyuki Okano · 2001 · Journal of Neuroscience
  5. Alzheimer’s disease after remote head injury: an incidence study
    Schofield, P W, Tang, M, Marder, K, Bell, K, Dooneief, G, Chun, M, Sano, M, Stern, Y, Mayeux, R · 1997 · Journal of Neurology, Neurosurgery & Psychiatry
  6. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer’s disease
    Ramesh J. L. Kandimalla, Maria Mańczak, Xiangling Yin, Rui Wang, P. Hemachandra Reddy · 2017 · Human Molecular Genetics · Retracted
  7. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease
    Shengnuo Fan, Yuqiu Zheng, Xuan Liu, Wenli Fang, Xiaoyu Chen, Wang Liao, Xiuna Jing, Ming Lei, Enxiang Tao, Qiu‐Lan Ma et al. · 2018 · Drug Delivery
  8. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand 18 F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
    Tobey J. Betthauser, Karly Alex Cody, Matthew D. Zammit, Dhanabalan Murali, Alexander K. Converse, Todd E. Barnhart, Charles K. Stone, Howard A. Rowley, Sterling C. Johnson, Bradley Christian · 2018 · Journal of Nuclear Medicine
  9. Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci
    Smith, D J, Escott-Price, V, Davies, G, Bailey, M E S, Colodro-Conde, L, Ward, J, Vedernikov, A, Marioni, R, Cullen, B, Lyall, D et al. · 2016 · Molecular Psychiatry
  10. Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils
    O'Nuallain, Brian, Freir, Darragh B., Nicoll, Andrew J., Risse, Emmanuel, Ferguson, Neil, Herron, Caroline E., Collinge, John, Walsh, Dominic M. · 2010 · The Journal of Neuroscience
  11. APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease
    Youmans, Katherine L., Tai, Leon M., Nwabuisi-Heath, Evelyn, Jungbauer, Lisa, Kanekiyo, Takahisa, Gan, Ming, Kim, Jungsu, Eimer, William A., Estus, Steve, Rebeck, G.William et al. · 2012 · Journal of Biological Chemistry
  12. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART
    Kaufman, Sarah K., Del Tredici, Kelly, Thomas, Talitha L., Braak, Heiko, Diamond, Marc I. · 2018 · Acta Neuropathologica
  13. Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
    Elina Zotova, James A. R. Nicoll, Raj N. Kalaria, Clive Holmes, Delphine Boche · 2010 · Alzheimer s Research & Therapy
  14. Elimination of prions by branched polyamines and implications for therapeutics
    Surachai Supattapone, Hoang-Oanh B. Nguyen, Fred E. Cohen, Stanley B. Prusiner, Michael R.D. Scott · 1999 · Proceedings of the National Academy of Sciences
  15. Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease: A Review
    Tanya C. Lye, Edwin Arthur Shores · 2000 · Neuropsychology Review
  16. The Role of p38 MAPK and Its Substrates in Neuronal Plasticity and Neurodegenerative Disease
    Corrêa, Sônia A. L., Eales, Katherine L. · 2012 · Journal of Signal Transduction
  17. Presynaptic Localization of Neprilysin Contributes to Efficient Clearance of Amyloid-β Peptide in Mouse Brain
    Nobuhisa Iwata, Hiroaki Mizukami, Keiro Shirotani, Yoshie Takaki, Shin‐ichi Muramatsu, Bao Lu, Norma P. Gerard, Craig J Gerard, Keiya Ozawa, Takaomi C. Saido · 2004 · Journal of Neuroscience
  18. Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
    Bing Bai, David Vanderwall, Yuxin Li, Xusheng Wang, Suresh Poudel, Hong Wang, Kaushik Kumar Dey, Ping‐Chung Chen, Ka Yang, Junmin Peng · 2021 · Molecular Neurodegeneration
  19. Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
    Leilei Chen, Qingqing Shen, Yingjuan Liu, Yunqi Zhang, Liping Sun, Xizhen Ma, Ning Song, Junxia Xie · 2025 · Signal Transduction and Targeted Therapy
  20. Cellular senescence and Alzheimer disease: the egg and the chicken scenario
    Saez-Atienzar, Sara, Masliah, Eliezer · 2020 · Nature Reviews Neuroscience
  21. The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons
    Rahman, Abdur, Ting, Kaka, Cullen, Karen M., Braidy, Nady, Brew, Bruce J., Guillemin, Gilles J. · 2009 · PLoS ONE
  22. Organic electrode coatings for next-generation neural interfaces
    Ulises Alejandro Aregueta Robles, Andrew J. Woolley, Laura Anne Poole-Warren, Nigel Hamilton Lovell, Rylie A. Green · 2014 · Frontiers in Neuroengineering
  23. Intermittent Fasting Alleviates the Increase of Lipoprotein Lipase Expression in Brain of a Mouse Model of Alzheimer's Disease: Possibly Mediated by β-hydroxybutyrate
    Jingzhu Zhang, Xinhui Li, Yahao Ren, Yue Zhao, Aiping Xing, Congmin Jiang, Yanqiu Chen, Li An · 2018 · Frontiers in Cellular Neuroscience
  24. Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review
    Gibbons, Garrett S., Lee, Virginia M. Y., Trojanowski, John Q. · 2019 · JAMA Neurology
  25. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
    Rola Ismail, Peter Parbo, Lasse Stensvig Madsen, Allan K. Hansen, Kim V. Hansen, Jeppe L. Schaldemose, Pernille Louise Kjeldsen, Morten Gersel Stokholm, Hanne Gottrup, Simon Fristed Eskildsen et al. · 2020 · Journal of Neuroinflammation
  26. Models of β-amyloid induced Tau-pathology: The long and “folded” road to understand the mechanism
    Stancu, Ilie-Cosmin, Vasconcelos, Bruno, Terwel, Dick, Dewachter, Ilse · 2014 · Molecular Neurodegeneration
  27. Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain
    Cox, Paul Alan, Davis, David A., Mash, Deborah C., Metcalf, James S., Banack, Sandra Anne · 2016 · Proceedings of the Royal Society B: Biological Sciences
  28. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer’s disease
    Ceyzériat, Kelly, Ben Haim, Lucile, Denizot, Audrey, Pommier, Dylan, Matos, Marco, Guillemaud, Océane, Palomares, Marie-Ange, Abjean, Laurene, Petit, Fanny, Gipchtein, Pauline et al. · 2018 · Acta Neuropathologica Communications
  29. A Long Journey into Aging, Brain Aging, and Alzheimer’s Disease Following the Oxidative Stress Tracks
    Patrizia Mecocci, Virginia Boccardi, Roberta Cecchetti, Patrizia Bastiani, Michela Scamosci, Carmelinda Ruggiero, Marta Baroni · 2018 · Journal of Alzheimer s Disease
  30. Entorhinal cortex dysfunction in Alzheimer's disease
    Kei M. Igarashi · 2022 · Trends in Neurosciences
  31. Rho Guanosine Triphosphatase Mediates the Selective Stabilization of Microtubules Induced by Lysophosphatidic Acid
    Tiffani A. Cook, Takayuki Nagasaki, Gregg G. Gundersen · 1998 · The Journal of Cell Biology
  32. Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates
    Benjamin Falcon, Annalisa Cavallini, Rachel C. Angers, Sarah J. Glover, Tracey K. Murray, Luanda Barnham, Samuel Jackson, Michael J. O'Neill, Adrian M. Isaacs, Michael L. Hutton et al. · 2014 · Journal of Biological Chemistry
  33. A set of functionally-defined brain regions with improved representation of the subcortex and cerebellum
    Benjamin A. Seitzman, Caterina Gratton, Scott A. Marek, Ryan V. Raut, Nico U.F. Dosenbach, Bradley L. Schlaggar, Steven E. Petersen, Deanna J. Greene · 2019 · NeuroImage
  34. Neural circuitry and immunity
    Pavlov, Valentin A., Tracey, Kevin J. · 2015 · Immunologic Research
  35. Amyloid-β Binds to the Extracellular Cysteine-rich Domain of Frizzled and Inhibits Wnt/β-Catenin Signaling
    Margaret H. Magdesian, Milena Carvalho, Fábio A. Mendes, Leonardo Martins Saraiva, María A. Juliano, Luiz Juliano, José Garcia-Abreu, Sergio Teixeira Ferreira · 2008 · Journal of Biological Chemistry
  36. ABBY
    Jeffrey L. Cummings, Sharon Cohen, Christopher H. van Dyck, Mark Brody, Craig T Curtis, William Cho, Michael Emmerson Ward, Michel J. Friesenhahn, Christina Rabe, Flávia Brunstein et al. · 2018 · Neurology
  37. Both total and phosphorylated tau are increased in Alzheimer's disease
    Magnus J.C. Sjögren · 2001 · Journal of Neurology Neurosurgery & Psychiatry
  38. TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading
    Martini-Stoica, Heidi, Cole, Allysa L., Swartzlander, Daniel B., Chen, Fading, Wan, Ying-Wooi, Bajaj, Lakshya, Bader, David A., Lee, Virginia M.Y., Trojanowski, John Q., Liu, Zhandong et al. · 2018 · Journal of Experimental Medicine
  39. Synaptic Changes in Alzheimer's Disease
    Gylys, Karen Hoppens, Fein, Jeffrey A., Yang, Fusheng, Wiley, Dorothy J., Miller, Carol A., Cole, Gregory M. · 2004 · The American Journal of Pathology
  40. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease
    Nguyen, Aivi T., Wang, Kui, Hu, Gang, Wang, Xuran, Miao, Zhen, Azevedo, Joshua A., Suh, EunRan, Van Deerlin, Vivianna M., Choi, David, Roeder, Kathryn et al. · 2020 · Acta Neuropathologica
  41. Amyloid‐β efflux from the central nervous system into the plasma
    Kaleigh F. Roberts, Donald Leo Elbert, Tom P. Kasten, Bruce W. Patterson, Wendy C. Sigurdson, Rose Connors, Vitaliy Ovod, Ling Y. Munsell, Kwasi G. Mawuenyega, Michelle M. Miller‐Thomas et al. · 2014 · Annals of Neurology
  42. A role for heme in Alzheimer's disease: Heme binds amyloid β and has altered metabolism
    Hani Atamna, William H. Frey · 2004 · Proceedings of the National Academy of Sciences
  43. Modifiable Risk Factors for Alzheimer’s Disease
    Edwards III, George A., Gamez, Nazaret, Escobedo Jr., Gabriel, Calderon, Olivia, Moreno-Gonzalez, Ines · 2019 · Frontiers in Aging Neuroscience
  44. Analysis of alternative splicing associated with aging and neurodegeneration in the human brain
    Tollervey, James R., Wang, Zhen, Hortobágyi, Tibor, Witten, Joshua T., Zarnack, Kathi, Kayikci, Melis, Clark, Tyson A., Schweitzer, Anthony C., Rot, Gregor, Curk, Tomaž et al. · 2011 · Genome Research
  45. Intracellular accumulation of amyloid-beta – a predictor for synaptic dysfunction and neuron loss in Alzheimer’s disease
    Bayer · 2010 · Frontiers in Aging Neuroscience
  46. Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease
    Dean, Douglas C., Hurley, Samuel A., Kecskemeti, Steven R., O’Grady, J. Patrick, Canda, Cristybelle, Davenport-Sis, Nancy J., Carlsson, Cynthia M., Zetterberg, Henrik, Blennow, Kaj, Asthana, Sanjay et al. · 2017 · JAMA Neurology
  47. MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies
    Trabzuni, Daniah, Wray, Selina, Vandrovcova, Jana, Ramasamy, Adaikalavan, Walker, Robert, Smith, Colin, Luk, Connie, Gibbs, J. Raphael, Dillman, Allissa, Hernandez, Dena G. et al. · 2012 · Human Molecular Genetics
  48. Protein phosphorylation in neurodegeneration: friend or foe?
    Tenreiro, Sandra, Eckermann, Katrin, Outeiro, Tiago F. · 2014 · Frontiers in Molecular Neuroscience
  49. RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration
    Diego Peretti, Amandine Bastide, Helois E. Radford, Nicholas Verity, Colin Molloy, Maria Guerra Martin, Julie A. Moreno, Joern R. Steinert, Tim Smith, Dr David Dinsdale et al. · 2015 · Nature
  50. Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration
    José Luis Labandeira-García, Ana Isabel Rodriguez-Perez, Pablo Garrido‐Gil, Jannette Rodríguez‐Pallares, José Luis Lanciego, María J. Guerra · 2017 · Frontiers in Aging Neuroscience
  51. Structure, function, and regulation of mitofusin‐2 in health and disease
    Gursimran Chandhok, Michael Lazarou, Brent Neumann · 2017 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
  52. Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications
    Andrea Tumminia, Federica Vinciguerra, Miriam Parisi, Lucia Frittitta · 2018 · International Journal of Molecular Sciences
  53. APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease
    Parhizkar, Samira, Holtzman, David M. · 2022 · Seminars in Immunology
  54. Presenilin-1 mutations and Alzheimer’s disease.
    Kelleher, Raymond J., Shen, Jie · 2017 · Proceedings of the National Academy of Sciences
  55. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration
    Edward Lewis Tobinick, Hyman Gross · 2008 · Journal of Neuroinflammation
  56. Rodent models of neuroinflammation for Alzheimer’s disease
    Amir Nazem, Roman Sankowski, Michael Bacher, Yousef Al‐Abed · 2015 · Journal of Neuroinflammation
  57. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration
    Hazel Urwin, Keith A. Josephs, Jonathan Daniel Rohrer, Ian R. Mackenzie, Manuela Neumann, Astrid Authier, Harro Seelaar, John Cornelis Van Swieten, Jeremy M. Brown, Peter Johannsen et al. · 2010 · Acta Neuropathologica
  58. Drosophila Models of Neurodegenerative Diseases
    Bingwei Lu, Hannes S. Vogel · 2008 · Annual Review of Pathology Mechanisms of Disease
  59. Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy
    Thomas Cope, Timothy Rittman, Robin Jacob Borchert, Peter Simon Jones, Deniz Vatansever, Kieren S. J. Allinson, Luca Passamonti, Patricia Vázquez Rodríguez, William Richard Bevan-Jones, John Tiernan O'Brien et al. · 2017 · Brain
  60. Genetic risk factors in Parkinson’s disease
    Kimberley J. Billingsley, Sara Bandrés‐Ciga, Sara Sáez-Atiénzar, Andrew Singleton · 2018 · Cell and Tissue Research
  61. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease
    Griffin, W Sue T, Mrak, Robert E · 2002 · Journal of Leukocyte Biology
  62. Deletion of the Ubiquitin Ligase CHIP Leads to the Accumulation, But Not the Aggregation, of Both Endogenous Phospho- and Caspase-3-Cleaved Tau Species
    Dickey, Chad A., Yue, Mei, Lin, Wen-Lang, Dickson, Dennis W., Dunmore, Judith H., Lee, Wing C., Zehr, Cynthia, West, Gemma, Cao, Songsong, Clark, Amber M. K. et al. · 2006 · The Journal of Neuroscience
  63. Novel Selective Allosteric Activator of the M1Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats
    Carrie K. Jones, Ashley E. Brady, Albert A. Davis, Zixiu Xiang, Michael Bubser, Mohammed Noor Tantawy, Alexander S. Kane, Thomas M. Bridges, J. Phillip Kennedy, Stefania Risso Bradley et al. · 2008 · Journal of Neuroscience
  64. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer’s disease
    Lynn Pulliam, Bing Sun, Maja Mustapić, Sahil Chawla, Dimitrios Kapogiannis · 2019 · Journal of NeuroVirology
  65. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17
    Luca Varani, Masato Hasegawa, Maria Grazia Spillantini, Michael J. Smith, Jill R. Murrell, Bernardino Francesco Ghetti, Aaron Klug, Michel Goedert, Gabriele Varani · 1999 · Proceedings of the National Academy of Sciences
  66. USP18 lack in microglia causes destructive interferonopathy of the mouse brain
    Goldmann, Tobias, Zeller, Nicolas, Raasch, Jenni, Kierdorf, Katrin, Frenzel, Kathrin, Ketscher, Lars, Basters, Anja, Staszewski, Ori, Brendecke, Stefanie M, Spiess, Alena et al. · 2015 · The EMBO Journal
  67. Amyloid β‐protein monomer structure: A computational and experimental study
    Andrij Baumketner, Summer L. Bernstein, Thomas Wyttenbach, Gal Bitan, David B. Teplow, Michael T. Bowers, Joan‐Emma Shea · 2006 · Protein Science
  68. Conformational transition of amyloid β-peptide
    Yechun Xu, Jianhua Shen, Xiaomin Luo, Weiliang Zhu, Kaixian Chen, Jianpeng Ma, Hualiang Jiang · 2005 · Proceedings of the National Academy of Sciences
  69. Neuroinflammation: A Common Pathway in CNS Diseases as Mediated at the Blood-Brain Barrier
    Michelle A. Erickson, Kenji Dohi, William A. Banks · 2012 · NeuroImmunoModulation
  70. Prefibrillar Amyloid Aggregates Could Be Generic Toxins in Higher Organisms
    Serena Baglioni, Fiorella Casamenti, Monica Bucciantini, Leila M. Luheshi, Niccolò Taddei, Fabrizio Chiti, Christopher Martin Dobson, Massimo Stefani · 2006 · Journal of Neuroscience
  71. The contribution of alpha synuclein to neuronal survival and function – Implications for Parkinson's disease
    Matthew J. Benskey, Ruth G. Perez, Fredric P. Manfredsson · 2016 · Journal of Neurochemistry
  72. Emptying the stores: lysosomal diseases and therapeutic strategies
    Frances M. Platt · 2017 · Nature Reviews Drug Discovery
  73. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's disease
    André F. Batista, Letícia Forny‐Germano, Julia Rosauro Clarke, Natalia M. Lyra e Silva, Jordano Brito‐Moreira, Susan E. Boehnke, Andrew Winterborn, Brian C. Coe, Ann Lablans, Juliana F.S. Vital et al. · 2018 · The Journal of Pathology
  74. Cholinergic Differentiation of Human Neuroblastoma SH-SY5Y Cell Line and Its Potential Use as an In vitro Model for Alzheimer’s Disease Studies
    Liana Marengo de Medeiros, Marco Antônio De Bastiani, Eduardo Pacheco Rico, Patrícia Schönhofen, Bianca Pfaffenseller, Bianca Wollenhaupt-Aguiar, Lucas Kich Grün, Florencia María Barbé‐Tuana, Eduardo Rigon Zimmer, Mauro A. A. Castro et al. · 2019 · Molecular Neurobiology
  75. Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
    Jeffrey L. Cummings · 2023 · Drugs
  76. Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET
    de Leon, Mony J., Li, Yi, Okamura, Nobuyuki, Tsui, Wai H., Saint-Louis, Les A., Glodzik, Lidia, Osorio, Ricardo S., Fortea, Juan, Butler, Tracy, Pirraglia, Elizabeth et al. · 2017 · Journal of Nuclear Medicine
  77. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor
    Andis Klegeris, Christopher J. Bissonnette, Patrick L. McGeer · 2003 · British Journal of Pharmacology
  78. Corticobasal degeneration: a pathologically distinct 4R tauopathy
    Kouri, Naomi, Whitwell, Jennifer L., Josephs, Keith A., Rademakers, Rosa, Dickson, Dennis W. · 2011 · Nature Reviews Neurology
  79. Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology
    M. Mahafuzur Rahman, Christofer Lendel · 2021 · Molecular Neurodegeneration
  80. Enhanced tau aggregation in the presence of Amyloid β
    Bennett, Rachel E., DeVos, Sarah L., Dujardin, Simon, Corjuc, Bianca, Gor, Rucha, Gonzalez, Jose, Roe, Allyson D., Frosch, Matthew P., Pitstick, Rose, Carlson, George A. et al. · 2017 · The American Journal of Pathology
  81. Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
    Folch, Jaume, Busquets, Oriol, Ettcheto, Miren, Sánchez-López, Elena, Castro-Torres, Ruben Dario, Verdaguer, Ester, Garcia, Maria Luisa, Olloquequi, Jordi, Casadesús, Gemma, Beas-Zarate, Carlos et al. · 2018 · Journal of Alzheimer s Disease
  82. Chronic Neurodegeneration After Traumatic Brain Injury: Alzheimer Disease, Chronic Traumatic Encephalopathy, or Persistent Neuroinflammation?
    Faden, Alan I., Loane, David J. · 2015 · Neurotherapeutics
  83. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss
    Jelena Scekic‐Zahirovic, Oliver Sendscheid, Hajer El Oussini, Mélanie Jambeau, Ying Sun, Sina Mersmann, Marina Wagner, Stéphane Dieterle, Jérôme Sinniger, Sylvie Dirrig‐Grosch et al. · 2016 · The EMBO Journal
  84. Mass Spectrometry-Based Protein Footprinting for Higher-Order Structure Analysis: Fundamentals and Applications
    Xiaoran Roger Liu, Mengru Mira Zhang, Michael L. Gross · 2020 · Chemical Reviews
  85. Cellular and pathological functions of tau
    Celeste Parra Bravo, Sarah A. Naguib, Li Gan · 2024 · Nature Reviews Molecular Cell Biology
  86. Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models
    Zhao, Yuhai, Calon, Frederic, Julien, Carl, Winkler, Jeremy W., Petasis, Nicos A., Lukiw, Walter J., Bazan, Nicolas G. · 2011 · PLoS ONE
  87. Amyloid-β Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP-Responsive Element-Binding Protein Pathway during Hippocampal Synaptic Plasticity
    Daniela Puzzo, Ottavio V. Vitolo, Fabrizio Trinchese, Joel P. Jacob, Agostino Palmeri, Ottavio Arancio · 2005 · Journal of Neuroscience
  88. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation
    Amadoro, Giuseppina, Ciotti, Maria Teresa, Costanzi, Marco, Cestari, Vincenzo, Calissano, Pietro, Canu, Nadia · 2006 · Proceedings of the National Academy of Sciences
  89. Selectively Reduced Expression of Synaptic Plasticity-Related Genes in Amyloid Precursor Protein + Presenilin-1 Transgenic Mice
    Dickey, Chad A., Loring, Jeanne F., Montgomery, Julia, Gordon, Marcia N., Eastman, P. Scott, Morgan, Dave · 2003 · The Journal of Neuroscience
  90. Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes
    Chung, Won-Suk, Verghese, Philip B., Chakraborty, Chandrani, Joung, Julia, Hyman, Bradley T., Ulrich, Jason D., Holtzman, David M., Barres, Ben A. · 2016 · Proceedings of the National Academy of Sciences
  91. Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease
    TCW, Julia, Goate, Alison M. · 2017 · Cold Spring Harbor Perspectives in Medicine
  92. A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models
    Wang, Weijin, Zhou, Qiuzhi, Jiang, Tao, Li, Shihong, Ye, Jinwang, Zheng, Jie, Wang, Xin, Liu, Yanchao, Deng, Minmin, Ke, Dan et al. · 2021 · Theranostics
  93. Apolipoprotein E: Diversity of Cellular Origins, Structural and Biophysical Properties, and Effects in Alzheimer's Disease
    Huang, Yadong, Weisgraber, Karl H., Mucke, Lennart, Mahley, Robert W. · 2004 · Journal of Molecular Neuroscience
  94. Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
    Overk, Cassia R., Masliah, Eliezer · 2014 · Biochemical Pharmacology
  95. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer?s A? peptides
    Xudong Huang, Craig Atwood, Robert D. Moir, Mariana A. Hartshorn, Rudolph E. Tanzi, Ashley Ian Bush · 2004 · JBIC Journal of Biological Inorganic Chemistry
  96. Early synaptic deficits in the APP/PS1 mouse model of Alzheimer’s disease involve neuronal adenosine A2A receptors
    Silvia Viana da Silva, Matthias Georg Haberl, Pei Zhang, Philipp Bethge, Cristina Lemos, Nélio Gonçalves, Adam Gorlewicz, Meryl Malézieux, Francisco Q. Gonçalves, Noëlle Grosjean et al. · 2016 · Nature Communications
  97. The Role of Microglia and Astrocytes in Huntington’s Disease
    Thulani Hansika Palpagama, Henry John Waldvogel, Richard L. M. Faull, Andrea Kwakowsky · 2019 · Frontiers in Molecular Neuroscience
  98. Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer’s disease
    Konstantinos Ioannis Avgerinos, Luigi Ferrucci, Dimitrios Kapogiannis · 2021 · Ageing Research Reviews
  99. SOD1 (Copper/Zinc Superoxide Dismutase) Deficiency Drives Amyloid β Protein Oligomerization and Memory Loss in Mouse Model of Alzheimer Disease
    Murakami, Kazuma, Murata, Nakaba, Noda, Yoshihiro, Tahara, Shoichi, Kaneko, Takao, Kinoshita, Noriaki, Hatsuta, Hiroyuki, Murayama, Shigeo, Barnham, Kevin J., Irie, Kazuhiro et al. · 2011 · Journal of Biological Chemistry
  100. Neurogenic Effect of  -Amyloid Peptide in the Development of Neural Stem Cells
    Lopez-Toledano, M. A. · 2004 · Journal of Neuroscience